tiprankstipranks
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
UK Market
AGY
Allergy Therapeutics
RESEARCH TOOLSreports

Allergy Therapeutics (AGY) Cash flow

18 Followers

Allergy Therapeutics Cash Flow

GB:AGY's free cash flow for Q2 2026 was £-14.52M. For the 2026 fiscal year, GB:AGY's free cash flow was decreased by £3.56M and operating cash flow was £-11.71M. See a summary of the company’s cash flow.
Cash Flow
Jun 25Jun 24Jun 23Jun 22Jun 21
Operating Cash Flow
£ -28.72M£ -32.14M£ -30.92M£ -14.11M£ 8.52M
Investing Cash Flow
£ -3.15M£ -1.20M£ -4.67M£ -3.06M£ -2.76M
Financing Cash Flow
£ 32.04M£ 31.43M£ 29.91M£ -2.64M£ -2.03M
End Cash Position
£ 12.79M£ 12.91M£ 14.85M£ 20.52M£ 40.27M
Free Cash Flow
£ -31.98M£ -35.54M£ -35.59M£ -17.17M£ 5.95M
Currency in GBP

Allergy Therapeutics Cash Flow